Story · Medicine & Biotech
Karine Tawagi: Phase II Proposal Explores Capivasertib Strategies in PTEN-Deficient Prostate Cancer
1 outlet · first reported by OncoDaily on
Karine Tawagi, assistant Professor of Clinical Medicine and Hematology/Oncology Fellowship Program Director at the University of Illinois Chicago, shared on X: “Phase II proposal for PTEN-deficient mAMPS. Patients with greater than (OncoDaily)
Coverage, in order
-
Karine Tawagi: Phase II Proposal Explores Capivasertib Strategies in PTEN-Deficient Prostate CancerKarine Tawagi, assistant Professor of Clinical Medicine and Hematology/Oncology Fellowship Program Director at the University of Illinois Chicago, shared on X: “Phase II proposal for PTEN-deficient mAMPS. Patients with greater than
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.